日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography-Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT Study

肿瘤科医生对经典霍奇金淋巴瘤中期正电子发射断层扫描适应性治疗方案选择的观察：真实世界 CONNECT 研究

期刊:Jco Oncology Practice
影响因子:4.6
doi:10.1200/OP.22.00811
Parsons, Susan K; Yu, Kristina S; Liu, Nicholas; Kumar, Supriya; Fanale, Michelle A; Holmes, Katie; Flores, Carlos; Surinach, Andy; Flora, Darcy R; Evens, Andrew M
淋巴瘤
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Retrospective Analysis With Propensity Score Matching of Peripheral T-Cell Lymphoma Treated Frontline With Brentuximab Vedotin and Chemotherapy

采用倾向评分匹配法对接受一线 Brentuximab Vedotin 和化疗治疗的外周 T 细胞淋巴瘤患者进行回顾性分析

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyad068
Burke, John M; Liu, Nicholas; Yu, Kristina S; Fanale, Michelle A; Surinach, Andy; Flores, Carlos; Lisano, Julie; Phillips, Tycel
细胞生物学
淋巴瘤
T细胞
发表日期：2023
文献求助 收藏

The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey

经典型霍奇金淋巴瘤对非正式照护者的影响：CONNECT横断面调查的结果

期刊:Supportive Care in Cancer
影响因子:3
doi:10.1007/s00520-023-08120-8
Flora, Darcy R; Evens, Andrew M; Liu, Nicholas; Yu, Kristina S; Byrd, Rachel; Fanale, Michelle A; Holmes, Katherine; Flores, Carlos; Surinach, Andy; Parsons, Susan K
淋巴瘤
发表日期：2023
文献求助 收藏

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

一项针对未经治疗的成人伯基特淋巴瘤患者，采用剂量调整的 EPOCH-R 方案进行风险适应性治疗的多中心研究

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.20.00303
Roschewski, Mark; Dunleavy, Kieron; Abramson, Jeremy S; Powell, Bayard L; Link, Brian K; Patel, Prapti; Bierman, Philip J; Jagadeesh, Deepa; Mitsuyasu, Ronald T; Peace, David; Watson, Peter R; Hanna, Wahid T; Melani, Christopher; Lucas, Andrea N; Steinberg, Seth M; Pittaluga, Stefania; Jaffe, Elaine S; Friedberg, Jonathan W; Kahl, Brad S; Little, Richard F; Bartlett, Nancy L; Fanale, Michelle A; Noy, Ariela; Wilson, Wyndham H
EPO
淋巴瘤
发表日期：2020
文献求助 收藏

A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

一项针对复发/难治性侵袭性B细胞和T细胞淋巴瘤的alisertib和romidepsin的1期临床试验

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2019.220012
Strati, Paolo; Nastoupil, Loretta J; Davis, Richard E; Fayad, Luis E; Fowler, Nathan; Hagemeister, Fredrick B; Kwak, Larry; Oki, Yasuhiro; Wang, Michael; Westin, Jason; Ruben, Charnelle E; Wesson, Emily T; Piekarz, Richard; Fanale, Michelle A; Lee, Hun Ju
B细胞
T细胞
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2020
文献求助 收藏

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study

ABVD联合利妥昔单抗对比ABVD单药治疗晚期高危经典型霍奇金淋巴瘤：一项随机II期研究

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2018.199844
Strati, Paolo; Fanale, Michelle A; Oki, Yasuhiro; Turturro, Francesco; Fayad, Luis E; Bartlett, Nancy L; Gladstone, Douglas E; Kasamon, Yvette L; Portlock, Carol S; Wilson, Wyndham H; Goy, Andre; Younes, Anas; Lee, Hun Ju
淋巴瘤
发表日期：2019
文献求助 收藏

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden

霍奇金淋巴瘤的全面基因组分析揭示了反复突变的基因和增加的突变负荷

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2018-0058
Liang, Winnie S; Vergilio, Jo-Anne; Salhia, Bodour; Huang, Helen J; Oki, Yasuhiro; Garrido-Laguna, Ignacio; Park, Haeseong; Westin, Jason R; Meric-Bernstam, Funda; Fabrizio, David; Miller, Vincent A; Stephens, Philip J; Fanale, Michelle A; Ross, Jeffrey S; Janku, Filip
淋巴瘤
发表日期：2019
文献求助 收藏

Lenalidomide plus rituximab (R(2) ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial

来那度胺联合利妥昔单抗（R(2)）治疗既往未接受治疗的边缘区淋巴瘤：一项开放标签 II 期试验的亚组分析和长期随访

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.15843
Becnel, Melody R; Nastoupil, Loretta J; Samaniego, Felipe; Davis, Richard E; You, M J; Green, Michael; Hagemeister, Fredrick B; Fanale, Michelle A; Fayad, Luis E; Westin, Jason R; Wang, Michael; Oki, Yasuhiro; Forbes, Sheryl G; Feng, Lei; Neelapu, Sattva S; Fowler, Nathan H
淋巴瘤
发表日期：2019
文献求助 收藏

Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas

一线使用布伦妥昔单抗联合CHP治疗CD30表达外周T细胞淋巴瘤的五年疗效

期刊:Blood
影响因子:23.1
doi:10.1182/blood-2017-12-821009
Fanale, Michelle A; Horwitz, Steven M; Forero-Torres, Andres; Bartlett, Nancy L; Advani, Ranjana H; Pro, Barbara; Chen, Robert W; Davies, Andrew; Illidge, Tim; Uttarwar, Mayur; Lee, Shih-Yuan; Ren, Hong; Kennedy, Dana A; Shustov, Andrei R
CD3
细胞生物学
T细胞
免疫/内分泌
CD30
淋巴瘤
T细胞
发表日期：2018
文献求助 收藏

Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study

剂量调整的 EPOCH-R 方案（依托泊苷、泼尼松、长春新碱、环磷酰胺、多柔比星和利妥昔单抗）治疗 MYC 重排的未经治疗的侵袭性弥漫性大 B 细胞淋巴瘤：一项前瞻性、多中心、单臂 II 期研究

期刊:Lancet Haematology
影响因子:17.7
doi:10.1016/S2352-3026(18)30177-7
Dunleavy, Kieron; Fanale, Michelle A; Abramson, Jeremy S; Noy, Ariela; Caimi, Paolo Fabrizio; Pittaluga, Stefania; Parekh, Samir; Lacasce, Ann; Hayslip, John W; Jagadeesh, Deepa; Nagpal, Sunil; Lechowicz, Mary Jo; Gaur, Rakesh; Lucas, Andrea; Melani, Christopher; Roschewski, Mark; Steinberg, Seth M; Jaffe, Elaine S; Kahl, Brad; Friedberg, Jonathan W; Little, Richard F; Bartlett, Nancy L; Wilson, Wyndham H
T细胞
淋巴瘤
EPO
细胞生物学
MYC
发表日期：2018
文献求助 收藏